Oxford University and AstraZeneca corona vaccine closed the vaccine trial when one person became ill. But the trial of the experimental Kavid-19 vaccine is being re-launched from Saturday. Such information has been known in a report of Bloomberg.
The University of Oxford is launching a trial of the vaccine after receiving a green signal from the UK government. They are back to work in full force.
Oxford said in a statement that the UK's Medicines Health Regulatory Authority (MHRA) had recommended a re-trial after reviewing the safety data. However, the participants did not reveal any information about their illness.
In a statement, AstraZeneca said the UK committee had completed the investigation. The Medicines Health Regulatory Authority has recommended that it be safe to resume trials in the UK.
Statements from AstraZeneca and Oxford on Saturday did not provide any information on trials outside the UK. Only reported trials inside the UK.
Source: Bloomberg.